Primary human immunodeficiency virus

Southern Medical Journal

Volumn 95, Issue 11, 2002, Pages 1312-1317

  Taiwo, Babafemi O ^a   Hicks, Charles B ^a  

^a Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; CYCLOSPORIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYDROXYUREA; IMMUNOMODULATING AGENT; VIRUS RNA; ZIDOVUDINE;

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LABORATORY DIAGNOSIS; NONHUMAN; PRIMARY INFECTION; REVIEW; SYMPTOMATOLOGY;

EID: 0036872328     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200295110-00016     Document Type: Review

References (64)

1. Khan JO, Walker BD: Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998; 339:33-39
2. Gaines H, von Sydow M, Pehrson PO, et al: Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988; 297:1363-1368
3. Dorrucci M, Rezza G, Vlahov D, et al: Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS 1995; 9:597-604
4. Tindall B, Barker S, Donovan B, et al: Characterization of the acute illness associated with human immunodeficiency virus infection. Arch Intern Med 1988; 148:945-949
5. Lange JMA, Parry JV, deWolf F, et al: Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS 1988; 2:31-35
6. Clement M, Hollander H: Natural history and management of the seropositive patient. The Medical Management of AIDS. Sande MA, Volberding PA (eds). Philadelphia, WB Sanders Co, 1992, pp 87-96
7. Schacker T, Collier AC, Hughes J, et al: Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-264
8. Rosenberg EC, Caliendo AM, Walker BD: Acute HIV infection among patients tested for mononucleosis. N Engl J Med 1999; 340:969
9. Needlestick transmission of HTLV-III from a patient infected in Africa (Editorial). Lancet 1984; 2:1376-1377
10. Lindback S, Brostrom C, Karlsson A, et al: Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200, AIDS and death from AIDS? BMJ1994; 30:1535-1537
11. Keet JP, Krijnen P, Koot M, et al: Predictors of rapid progression to AIDS in HIV seroconverters. AIDS 1993; 7:51-57
12. Henrard DR, Daar E, Farzadegan H, et al: Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:305-310
13. Schacker TW, Hughes JP, Shea T, et al: Biologic and virologic characteristics of primary HIV infection. Ann Intern Med 1998; 128:613-620
14. Al Harthi L, Siegel J, Spritzler J, et al: Maximum suppression of HIV replication leads to restoration of HIV-specific responses in early HIV disease. AIDS 2000; 14:761-770
15. Pedersen C, Lindhart BO, Jensen BL, et al: Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ1989; 299:154-157
16. Malhotra U, Berrey MM, Huang Y, et al: Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. J Infect Dis 2000; 181:121-131
17. Carcelain G, Blane C, Leibowitch J, et al: T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS 1999; 13:1077-1081
18. Oxenius A, Price DA, Easterbrook PJ, et al: Early active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA 2000; 97:3382-3387
19. Capillupi B, Ciuffreda GP, Sciandra M, et al: Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters. J Biol Regul Homeost Agents 2000; 14:58-62
20. Yerly S, Kaiser L, Perneger TV, et al: Time of initiation of antiretroviral therapy: impact on HIV-1 viremia. The Swiss HIV Cohort Study. AIDS 2000; 14:243-249
21. Cenci A, Bertoli A, Tambusi G, et al: Viral dynamics and mutation in the pol gene during primary HIV-1 infection. J Biol Regul Homeost Agents 2000; 14:7-10
22. Rosenberg ES, Altfeld M, Poon SH, et al: Immune control of HIV-1 after treatment of acute infection. Nature 2000; 407:523-526
23. Jacquez JA, Koopman JS, Simon CP, et al: Role of primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994; 7:1169-1184
24. Dickover RE, Garraty EM, Hennan SA, et al: Identification of levels of maternal HIV-RNA associated with risk of perinatal transmission. effects of maternal zidovudine treatment on viral load. JAMA 1996; 275:599-605
25. Lee TH, Sakahara N, Fiebeg E, et al: Correlation of HIV RNA level in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr 1996; 2:427-428
26. Busch MP, Operskalski EA, Mosley JW, et al: Factors affecting human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis 1996; 174:26-33
27. Royce RA, Sena A, Cates W Jr, et al: Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078
28. Koopman JS, Jacquez A, Welch GW, et al: The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:249-250
29. Cates WJ, Chesney MA, Cohen MS: Primary HIV infection. a public health opportunity. Am J Public Health 1997; 87:1928-1930
30. Shacker T, Little S, Connick B, et al: Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis 2000; 181:354-357
31. Roos M, De Leeuw N, Claessen F, et al: Viro-immunological studies in acute HW HIV-1 infection. AIDS 1994; 8:1533-1538
32. Zaunders J, Carr A, McNally L, et al: Effects of primary HIV1 infection on subsets of CD4+ and CD8+ T lymphocytes. AIDS 1995; 9:561-566
33. Connik B, Marr D, Zhang X, et al: HIV-specific cellular and humoral immune responses in HIV infection. AIDS Res Hum Retroviruses 1996; 12:1129-1140
34. Koup RA, Safrit JT, Cao Y, et al: Temporal association of cellular immune responses with initial control of viremia in primary immunodeficiency virus type I syndrome. J Virol 1994; 68:4650-4655
35. Price DA, O'Callaghan CA, Whelan JA, et al: Cytotoxic lymphocytes and viral evolution in primary HIV-1 infection. Clin Sci 1999; 97:707-718
36. Soudney H, Pantaleo G: New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection. J Biol Regul Homeost Agents 1997; 11:37-39
37. Little SJ, McLean AR, Spina CA, et al: Viral dynamics of acute HIV infection. J Exp Med 1999; 190:841-850
38. Vanhems P, Allard R, Cooper DA, et al: Acute human immunodeficiency virus type I disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24:965-970
39. Vanhems P, Dassa C, Lambert J, et al: Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 21:99-106
40. Kinloch-de Loes S, de Saussure P, Saurat JH, et ah al: Symptomatic primary infection due to human immunodeficiency virus type 1. review of 31 cases. Clin Infect Dis 1993; 17:59-65
41. Sinicco A, Palestro G, Caramello P, et al: Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr 1990; 3:260-265
42. Daar ES, Little S, Pitts J, et al: Diagnosis of primary HIV infection. Los Angeles County primary HIV recruitment network. Ann Intern Med 2001; 134:25-29
43. Pena JM, Martinez-Lopez MA, Arnalich F, et al: Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. Rev Infect Dis 1991; 13:872-875
44. Moss PJ, Read RC, Kudesia G, et al: Prolonged cryptosporodiosis during primary HIV infection. J Infect 1995; 30:51-53
45. Lapins J, Lindback S, Lidbrink P, et al: Mucocutaneous manifestations in 22 consecutive cases of primary HIV-1 infection. Br J Dermatol 1996; 134:257-261
46. LeBoit PB: Dermatopathologic findings in patients with HIV. Dermatol Clin 1992; 10:59-71
47. Denning DW: The neurological features of acute HIV. Biomed Pharmacother 1988; 42:11-14
48. Lima J, Ribera A, Garcia-Bragado G, et al: Antiplatelet antibodies in primary infection by human immunodeficiency virus (Letter). Ann Intern Med 1987; 106:33
49. Flemmer M, Oldfield BC, Melek B: Acute retroviral disease masquerading as bacterial sepsis: the "bands" play on. South Med J 1996; 89:354-355
50. Busch MP: HIV and blood transfusion; focus on seroconversion. Vox Sang 1994; 67:13-18
51. Busch MP, Lee LL, Satten GA, et al: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35:91-97
52. Rich JD, Merriman NA, Mylonakis E, et al: Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999; 130:37-39
53. Carpenter CC, Cooper OA, Fischl MA, et al: Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA panel. JAMA 2000; 283:381-390
54. Department of Health and Human Services/Kaiser Family Foundation: Panel on Clinical Practices for the Treatment of HIV Infection. guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at http://www.hivatis.org. Accessed January 2000
55. Chun TW, Engel D, Berrey MM, et al: Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 1998; 95:8869-8873
56. Lillo FB, Ciuffreda D, Veglia F, et al: Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection. AIDS 1999; 13:791-796
57. Poggi C, Profizi N, Djediouane A, et al: Long-term evaluation of triple nucleoside therapy administered for primary HIV-1 infection. AIDS 1999; 13:1213-1220
58. Daar ES, Bai J, Hausner MA, et al: Acute HIV syndrome following discontinuation of antiretroviral therapy in a patient treated before seroconversion. Ann Intern Med 1998; 128:827-829
59. Kinloch-de Loes S, Perneger TV: Primary HIV infection: follow up of patients initially randomized to zidovudine or placebo. J Infect 1997; 35:111-116
60. Rizzardi GP, Vaccarezza M, Capiluppi B, et al: Cyclosporine A in combination with HAART in primary HIV-1 infection. J Biol Regul Homeost Agents. 2000; 14:79-81
61. Lori F, Jessen H, Lieberman J, et al: Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis 1999; 180:1827-1832
62. Lori F, Lisziewicz J: Role of immune modulation in primary HIV infection. J Biol Regul Homeost Agents 2000; 14:45-48
63. Tamalet C, Pasquier C, Colson P, et al: Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1. J Med Virol 2000; 61:181-186
64. Hirsch MS, Brun-Vezinet F, D'Aquila RT, et al: Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA 2000; 283:2417-2426